Morgan Stanley’s Xenetic Biosciences XBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$16 Hold
4
﹤0.01% 8014
2025
Q1
$11 Buy
4
+3
+300% +$8 ﹤0.01% 8011
2024
Q4
$4 Hold
1
﹤0.01% 7938
2024
Q3
$4 Hold
1
﹤0.01% 7896
2024
Q2
$4 Hold
1
﹤0.01% 7816
2024
Q1
$4 Sell
1
-1
-50% -$4 ﹤0.01% 7791
2023
Q4
$6 Sell
2
-293
-99% -$879 ﹤0.01% 7795
2023
Q3
$1.45K Hold
295
﹤0.01% 7181
2023
Q2
$967 Hold
295
﹤0.01% 7300
2023
Q1
$1.2K Sell
295
-302
-51% -$1.23K ﹤0.01% 7327
2022
Q4
$1.7K Buy
597
+2
+0.3% +$6 ﹤0.01% 7396
2022
Q3
$4K Sell
595
-670
-53% -$4.5K ﹤0.01% 7332
2022
Q2
$10K Sell
1,265
-2
-0.2% -$16 ﹤0.01% 7214
2022
Q1
$13K Buy
1,267
+2
+0.2% +$21 ﹤0.01% 7319
2021
Q4
$16K Buy
1,265
+747
+144% +$9.45K ﹤0.01% 7307
2021
Q3
$11K Buy
518
+292
+129% +$6.2K ﹤0.01% 7292
2021
Q2
$5K Hold
226
﹤0.01% 7399
2021
Q1
$5K Buy
226
+200
+769% +$4.43K ﹤0.01% 7117
2020
Q4
$1K Hold
26
﹤0.01% 6976
2020
Q3
$0 Hold
26
﹤0.01% 6839
2020
Q2
$0 Hold
26
﹤0.01% 6735
2020
Q1
$0 Hold
26
﹤0.01% 6721
2019
Q4
$0 Hold
26
﹤0.01% 6777
2019
Q3
$0 Sell
26
-3,582
-99% ﹤0.01% 6769
2019
Q2
$406K Buy
3,608
+3,582
+13,777% +$403K ﹤0.01% 4713
2019
Q1
$6K Hold
26
﹤0.01% 6301
2018
Q4
$5K Buy
26
+1
+4% +$192 ﹤0.01% 6302
2018
Q3
$9K Sell
25
-1
-4% -$360 ﹤0.01% 6334
2018
Q2
$13K Buy
26
+9
+53% +$4.5K ﹤0.01% 6244
2018
Q1
$4K Hold
17
﹤0.01% 6432
2017
Q4
$4K Hold
17
﹤0.01% 6366
2017
Q3
$4K Hold
17
﹤0.01% 6330
2017
Q2
$6K Sell
17
-32
-65% -$11.3K ﹤0.01% 6327
2017
Q1
$27K Hold
49
﹤0.01% 5996
2016
Q4
$26K Buy
+49
New +$26K ﹤0.01% 5938